Chowdhury S K, Chait B T
Rockefeller University, New York, New York 10021.
Anal Biochem. 1989 Aug 1;180(2):387-95. doi: 10.1016/0003-2697(89)90451-x.
The utility of a new mass spectrometric technique for detecting and identifying peptide by-products produced in the synthesis of peptides is demonstrated. The technique involves three sequential steps: (1) practically nondestructive 252Cf plasma desorption mass spectrometric analysis of monolayer amounts of the peptide(s) of interest bound to a thin layer of nitrocellulose; (2) enzyme-catalyzed microscale chemical reaction of the surface-bound peptide(s) to produce structurally informative hydrolysis products; (3) plasma desorption mass spectrometric analysis of these hydrolysis products. The first step determines the presence and the molecular weights of unwanted by-products resulting from errors or incomplete reactions during synthesis. The subsequent two steps provide information on the precise location in the peptides where errors have occurred. In the present paper, the technique is applied to an investigation of unwanted peptide by-products associated with the use of tryptophan during stepwise solid-phase peptide synthesis. Synthetic preparations of melittin and [Bpa-8]dynorphin A (1-17) were each found to contain a major impurity with molecular weight 28 Da higher than that of the desired product. The impurity in the melittin preparation, in which the final deprotection step involved the high-low HF procedure, was shown to result from incomplete removal of the formyl group from Trp-19. On the other hand, the impurity in the [Bpa-8]dynorphin A (1-17) preparation, where the removal of the formyl group from Trp-14 was carried out using piperidine, was shown to result from migration of the formyl group to Lys-11 or Lys-13.(ABSTRACT TRUNCATED AT 250 WORDS)
一种用于检测和鉴定肽合成过程中产生的肽副产物的新质谱技术的实用性得到了证明。该技术包括三个连续步骤:(1)对结合在硝酸纤维素薄层上的感兴趣的单层肽进行几乎无损的252Cf等离子体解吸质谱分析;(2)对表面结合的肽进行酶催化的微尺度化学反应,以产生具有结构信息的水解产物;(3)对这些水解产物进行等离子体解吸质谱分析。第一步确定合成过程中由于错误或反应不完全而产生的不需要的副产物的存在和分子量。随后的两个步骤提供了关于肽中错误发生的确切位置的信息。在本文中,该技术被应用于研究逐步固相肽合成过程中与色氨酸使用相关的不需要的肽副产物。发现蜂毒素和[Bpa-8]强啡肽A(1-17)的合成制剂中均含有一种主要杂质,其分子量比所需产物高28 Da。蜂毒素制剂中的杂质,其最终脱保护步骤涉及高低HF程序,结果表明是由于Trp-19上的甲酰基未完全去除。另一方面,[Bpa-8]强啡肽A(1-17)制剂中的杂质,其中使用哌啶从Trp-14上去除甲酰基,结果表明是由于甲酰基迁移至Lys-11或Lys-13。(摘要截短于250字)